Jill Stopfer on the Benefits of Multigene Panel Testing
Jill Stopfer, MS, CGC, Senior Genetic Counselor, Abramson Cancer Center, University of Pennsylvania, discusses the benefits of multigene panel testing.
PVd Confers a Small OS Benefit to Patients With Relapsed/Refractory Multiple Myeloma
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
